沃华医药（002107）8月25日主力资金净流出1140.71万元

Group 1 - The core viewpoint of the news highlights the financial performance and stock activity of Wohuah Pharmaceutical, indicating a modest increase in stock price and significant growth in net profit [1][3] - As of August 25, 2025, Wohuah Pharmaceutical's stock closed at 7.01 yuan, with a trading volume of 168,500 hands and a transaction amount of 118 million yuan [1] - The company reported total revenue of 425 million yuan for the first half of 2025, reflecting a year-on-year growth of 7.64%, while net profit attributable to shareholders reached 44.68 million yuan, up 303.16% [1] Group 2 - The company has a liquidity ratio of 2.343 and a quick ratio of 1.957, indicating strong short-term financial health [1] - Wohuah Pharmaceutical has made investments in five companies and participated in 5,000 bidding projects, showcasing its active engagement in the market [2] - The company holds 25 trademark registrations and 54 patents, along with 31 administrative licenses, reflecting its commitment to innovation and compliance [2]